Mass home screening for asymptomatic SARS-CoV-2 infection unlikely to reduce transmission

NewsGuard 100/100 Score

Encouraging self-testing at home twice a week for all adults in England, and soon Scotland, is a misguided policy, unlikely to reduce transmission, warn public health experts in The BMJ today.

In an editorial, Angela Raffle and Mike Gill, Public Health Consultants with experience in both communicable disease control and screening programs, say that the UK is not yet succeeding in testing, and supporting to isolate, everyone with symptoms and their contacts.

Coronavirus tests per case detected are already higher in the UK than anywhere in the world, they write, and the value of adding universal low-risk testing is unknown, yet is being introduced without plans to measure the costs and consequences.

They acknowledge that response in a pandemic requires speed, but say without training and proficiency testing for those taking and reading samples, plus a robust process for ensuring appropriate actions follow a test result, “SARS-CoV-2 self-testing by asymptomatic members of the public is unlikely to reduce transmission.”

A key justification cited by government for mass testing of asymptomatic people at low risk is the assertion that “up to one third” of cases are symptomless, they write. Yet evidence is growing that transmission arises overwhelmingly from people with symptomatic infections and their contacts.

The UK is an outlier globally in placing such emphasis on asymptomatic testing, they add, pointing out that the World Health Organization has never advised testing low risk people, and both the EU and the US Centers for Disease Control and Prevention (CDC) recommend screening tests only for those where risk is highest.

They argue that the challenge for the UK now is to use the past year’s learning, the new laboratory capacity, and the availability of rapid tests to best effect. “Current efforts are undermined by secrecy, quality failures, underused capacity, and a misplaced focus on low yield uses,” they write.

“Both the laboratories and the rapid tests could be targeted to deliver a substantially more effective and cost effective testing service founded on the public service principles of sound evaluation, strong ethics, high quality, and full transparency.”

Source:
Journal reference:

Raffle, A.E., et al. (2021) Mass screening for asymptomatic SARS-CoV-2 infection. BMJ. doi.org/10.1136/bmj.n1058.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity